Ania Jastreboff
Ania Jastreboff is a prominent Yale University professor and researcher in the field of obesity and metabolic disorders. She is known for her groundbreaking work in developing and studying new weight loss medications, including Retatrutid. Her recent presentation at an obesity conference in Venice highlighted the impressive results of her study, which showed that participants lost an average of 24.2% of their body weight over 48 weeks, sparking interest in new treatment options for obesity.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Greece | 1 | 7.00 | 0.09% | +0% | 10,423,054 | 9,224 | $190,000 | 168$ |
| Totals | 1 | 10,423,054 | 9,224 | $190,000 | 168$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Greece:
Ania Jastreboff is the director of the Yale Obesity Research Center and the lead author of a 2023 study.
7
Norway:
Ania Jastreboff is a Yale professor who led the phase 2 study on the latest type of weight loss medication, Retatrutid.
8
Norway:
Ania Jastreboff is a Yale professor who presented results from a study on a new type of weight loss medication.
9
Norway:
Ania Jastreboff is a Yale professor who presented results from a study on a new type of weight loss medication.
9